Pathological periarticular hypervascularization

Pathological periarticular hypervascularization" refers to the abnormal or excessive formation of blood vessels in the tissues surrounding a joint. This phenomenon is typically seen as a secondary consequence of underlying pathological processes such as chronic inflammation (e.g., rheumatoid arthritis, hemophilic arthropathy), benign or malignant tumors (e.g., synovial hemangiomas), or reparative responses after trauma. It may present radiologically or histologically as increased vascularity in the periarticular tissues and can contribute to clinical symptoms such as swelling, pain, and in some cases, bleeding or joint destruction. It is not a specific molecular entity, receptor, or direct therapeutic target, but reflects a process driven by dysregulation of angiogenic signaling pathways (e.g., VEGF, FGF) in the context of disease[2]. In summary, this is not a canonical target, receptor, or molecule, but a pathologic process; targeting may involve general anti-angiogenic therapies, but these are not specific to a unique molecule named "pathological periarticular hypervascularization," so all structured fields referring to molecular targets should be null.

Other names

Periarticular hypervascularizationPathological periarticular neovascularizationPeriarticular angiogenesis